IVERIC bio
Princeton
About IVERIC bio
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $857.9M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2022)
- Ticker: nasdaq:ISEE
- Website: ivericbio.com
- Phone: 609.945.6050
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/iveric-bio-162906 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.